| | Class 2 Device Recall Tosoh Bioscience HLC723G8
Analyzer |  |
| Date Initiated by Firm | November 07, 2016 |
| Create Date | February 17, 2017 |
| Recall Status1 |
Terminated 3 on February 09, 2021 |
| Recall Number | Z-1225-2017 |
| Recall Event ID |
75727 |
| 510(K)Number | K071132 K131580 |
| Product Classification |
Control, hemoglobin, abnormal - Product Code JCM
|
| Product | Tosoh Bioscience HLC-723G8 Analyzer for HbA1c testing. |
| Code Information |
All active analyzers |
| FEI Number |
1000123732
|
Recalling Firm/ Manufacturer |
Tosoh Bioscience, Inc. 6000 Shoreline Ct Ste 101 South San Francisco CA 94080-7606
|
| For Additional Information Contact | Susan H. Koss 614-317-1909 |
Manufacturer Reason for Recall | The device defect associated with this recall may result in HbA1c values with a negative bias in patients with the hemoglobin variants C, D, E and S. The negative bias occurs at the higher levels of HbA1c, e.g. 9%, but not at the diagnostic medical decision point of 6.5%. |
FDA Determined Cause 2 | Software design |
| Action | Recall notification letters were distributed to customers on 11/7/16. The letters instructed customers to review the chormatography to determine whether or not a variant peak was detected. If so, restest the sample using an alternative method. |
| Quantity in Commerce | 682 analyzers |
| Distribution | Worldwide distribution. The products were shipped to the following states: AK, AL, AR, AZ, CA, CO, CT, DE, FL, GA, IA, ID, IL IN, KS, KY, LA, MA, MD, ME, MI, MN, MO, MS, NC, ND, NE, NH, NJ, NM, NV, NY, OH, OK, OR, PA, RI, SC, SD, TN, TX, UT, VA, VT, WA, WI, WV, AND WY.
The recalled products were shipped to the following countries: Brazil, Chile, Columbia, Guatemala, Costa Rica, Dominican Republic, Eduador, Nicaragua, Panama, Peru, Puerto Rico, Uruguay, |
| Total Product Life Cycle | TPLC Device Report |
|
1 A record in this database is created when a firm initiates a correction or removal action. The record is updated if the FDA identifies a violation and classifies the action as a recall, and it is updated for a final time when the recall is terminated. Learn more about medical device recalls. 2 Per FDA policy, recall cause determinations are subject to modification up to the point of termination of the recall. 3 For details about termination of a recall see Code of Federal Regulations (CFR) Title 21 §7.55.
|
| 510(K) Database | 510(K)s with Product Code = JCM
|
|
|
|